目的: 完善复方乙酰水杨酸片的质量标准, 提高其质量控制水平。方法: 采用《中华人民共和国药典》2015 年版四部相关方法和拟定标准方法, 对复方乙酰水杨酸片拟定的质控项目进行检验, 建立复方乙酰水杨酸片的薄层色谱鉴别方法, 建立HPLC 同时测定HPLC 鉴别（1）、游离水杨酸、溶出度、含量均匀度和含量测定的方法, 同时以3 个主成分为目标, 建立了该片剂的溶出度方法。结果: HPLC 鉴别和薄层色谱鉴别专属性强, 简便快速;建立了HPLC 测定游离水杨酸、溶出度、含量均匀度和含量测定, 其线性关系均较好, 重复性良好, 回收率均符合要求。9 批次复方乙酰水杨酸片的游离水杨酸含量为0. 1%~0. 3%, 含量均匀度（咖啡因）结果为98. 0%~102. 9%, 含量测定（乙酰水杨酸）结果为97. 9%~101. 7%, 含量测定（非那西丁）结果为98. 1%~103. 9%, 含量测定（咖啡因）结果为96. 8%~103. 1%, 溶出度结果大多在79%~101% 之间, 部分企业溶出度检测不合格;建议游离水杨酸限度修订为0. 3%, 溶出度限度均为75%。结论: 本研究完善和提高了复方乙酰水杨酸片的质量控制方法。
Objective: To improve the quality standard of compound acetylsalicylic acid tablets and improve its quality control level. Methods: The proposed quality control items of compound acetylsalicylic acid tablets were determined according to the ChP（2015 edition, volume 4）. The TLC identification method were established. The HPLC method for HPLC identification（1）, free salicylic acid, dissolution, content uniformity and content determination were established at the same time. The tablets dissolution method were established with three principal components in compound acetylsalicylic acid tablets. Results: The methods of HPLC identification（1） and TLC identification（2）were specific, simple and rapid. The HPLC methods for determination of free salicylic acid, dissolution, content uniformity and content determination were established, their linearity and repeatability were good. The recovery results were conformed to the requirements. The ranges for the free salicylic acid contents and content uniformity（caffeine）of 9 batches were 0. 1%-0. 3% and 98. 0%-102. 9%. The ranges for the content determination of acetyl salicylic acid, phenacetin and caffeine were 97. 9%-101. 7%, 98. 1%-103. 9% and 96. 8%-103. 1% respectively. The dissolution of aspirin phenacetin and caffeine（APC）were mostly between 79%-101%. Dissolution results from some companies were failed. The limit of each test items for compound acetylsalicylic acid tablets were proposed as follows: limit of free salicylic acid was 0. 3%, the dissolution limit of APC was 75%. Conclusion: The established method improves the quality control of compound acetylsalicylic acid tablets.
[1] 中国人民共和国药典2015 年版. 二部[S]. 2015: 1216
ChP 2015. Vol ⅡhP 2015. Vol Ⅱ[S]. 2015: 1216
[2] USP 41-NF 36[S]. 2018: 42
[3] 常书阳, 陈玉海, 郑梅花. HPLC 法测定复方乙酰水杨酸片的含量及有关物质[J]. 药物分析杂志, 2007, 27(8): 1252
CHANG SY, CHEN YH, ZHENG MH. HPLC determination of compound aspirin tablets[J]. Chin J Pharm Anal, 2007, 27(8): 1252
[4] 王腾, 王晓敏, 张亚运. 高效液相色谱法同时测定复方乙酰水杨酸片中各有效成分的含量[J]. 北京石油化工学院学报, 2012, 20(1): 41
WANG T, WANG XM, ZHANG YY. Simultaneous determination of three components in compound aspirin tablets by HPLC[J]. J Beijing Inst Petro-chem Technol, 2012, 20(1): 41
[5] 刘莹, 关玲, 徐恒峰, 等. 薄层色谱法鉴定APC 药片组分的实验条件优化[J]. 大学化学, 2014, 28(4): 36
LIU Y, GUAN L, XU HF, et al. Thin layer chromatography identification of APC tablets components optimized experimental conditions[J]. Univ Chem, , 2014, 28(4): 36
[6] 万燕, 付小六, 王伟. 薄层色谱法同时鉴别复方对乙酰氨基酚片与复方乙酰水杨酸片中3 种成分[J]. 中国药品标准, 2003, 4(5): 49
WANG Y, FU XL, WANG W. Identification determination of three components in compound paracetamol tablets and compound aspirin tablets by TLC[J]. Drug Stand China, 2003, 4(5): 49
[7] 王少波, 杨延风, 刘丽翔. 薄层色谱法快速鉴别复方乙酰水杨酸片中的三种成分[J]. 首都医药, 2001, 8(1): 42
WANG SB, YANG YF, LIU LX. Thin layer chromatography to quickly identify the three components of compound aspirin tablets[J]. Cap Med, 2001, 8(1): 42
[8] 张秋萍, 吴立城, 刘安喜. 薄层色谱法测定复方乙酰水杨酸药片的含量[J]. 色谱, 1990, 8(3): 193
ZHANG QP, WU LC, LIU AX. Determination of the contenti ncompounda spirin tablets by TLC[J]. Chin J Chromatogr, 1990, 8(3): 193
[9] 张启明, 谢沐风, 宁保明, 等. 采用多条溶出曲线评价口服固体制剂的内在质量[J]. 中国医药工业杂志, 2009, 40(12): 946
ZHANG QM, XIE MF, NING BM, et al. Evaluation of solid oral products by dissolution profiles in different mediums[J]. Chin J Pharm, 2009, 40(12): 946
[10] 谢沐风. 如何科学、客观地制定溶出度试验质量标准[J]. 中国医药工业杂志, 2012, 43(3): A23
XIE MF. How to develop and validate the dissolution test on the quality criteria[J]. Chin J Pharm, 2012, 43(3): A23
[11] 胡昌勤, 潘瑞雪. 溶出度试验评价/ 预测固体口服制剂生物等效性的研究进展[J]. 中国新药杂志, 2014, 23(3): 44
HU CQ, PAN RX. Progress in evaluation/prediction of bioequivalence of solid oral preparations by dissolution test[J]. Chin J New Drugs, 2014, 23(3): 44
[12] 国家药典委员会. 国家药品标准工作手册(第四版)[M]. 北京: 中国医药科技出版社, 2013
Chinese Phamacopoiea Committee. The national drug standards work manual(4 th Ed)[M]. Beijing: China Medical Science Press, 2013
[13] 中华人民共和国药典2015 年版. 二部[S]. 2015: 544, 1220
ChP 2015. Vol ⅡhP 2015. Vol Ⅱ[S]. 2015: 544, 1220
[14] 刘洁, 刘辉. 阿司匹林肠溶片质量研究与分析[J]. 药物分析杂志, 2015, 35(12): 2187
LIU J, LIU H. Quality evaluation and analysis of domestic asipirin enteric-coated tablets[J]. Chin J Pharm Anal, 2015, 35(12): 2187
[15] 王怀友, 汪成, 郑玉忠, 等. 毛冬青质量标准的改进研究[J]. 药物分析杂志, 2019, 39(8): 1416
WANG HY, WANG C, ZHENG YZ, et al. Study on the quality standard of IlicisPubescentis Radix et Caulis[J]. Chin J Pharm Anal, 2019, 39(8): 1416
